Psoriasis-Reference-Cited by-同舟云学术

Psoriasis

Published:1994-02 Issue:2 Volume:1 Page:157-167
ISSN:1172-7039
Container-title:Clinical Immunotherapeutics
language:en
Short-container-title:Clin. Immunother.

Author:

Phillips William G.,Breathnach Stephen M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/BF03258501.pdf

Reference106 articles.

1. Camp RDR. Psoriasis. In: Champion R, Burton J, Ebling FGJ, editors. Textbook of dermatology, 5th edition. Oxford: Blackwell Scientific Publications, 1991: 1391–457

2. Lever WF, Schaumburg-Lever G. Histopathology of the skin, 7th edition. Philadelphia: JB Lippincott Company, 1990

3. Fry L. Psoriasis. Br J Dermatol 1988; 119: 445–61

4. Bos JD. The pathomechanisms of psoriasis; the skin immune system and cyclosporin. Br J Dermatol 1988; 118: 141–55

5. Streilein JW. Speculations on the immunopathogenesis of psoriasis: T-cell violation of a keratinocyte sphere of influence. J Invest Dermatol 1990; 95: 20S–21S

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of copper/zinc superoxide dismutase as a nitric oxide-regulated gene in human (HaCaT) keratinocytes: implications for keratinocyte proliferation;BIOCHEM J;2000

2. Evolution of texture in aggregates of crystals exhibiting both slip and twinning;Modelling and Simulation in Materials Science and Engineering;1999-11-01

3. Tazarotene in combination with topical corticosteroids;Journal of the American Academy of Dermatology;1998-10

4. The pathogenesis of psoriasis and the mechanism of action of tazarotene;Journal of the American Academy of Dermatology;1998-10

5. Tazarotene: a review of its pharmacological profile and potential for clinical use in psoriasis;Expert Opinion on Investigational Drugs;1997-10